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Aim: The aim was to provide a dosimetric comparison between IMRT and RapidArc treatment
plans with RPI index with simultaneous comparison of the treatment delivery time.
Background: IMRT and RapidArc provide highly conformal dose distribution with good spar-
ing  of normal tissues. However, a complex spatial dosimetry of IMRT and RapidArc plans
hampers the evaluation and comparison between plans calculated for the two modalities.
RPI  was used in this paper for treatment plan comparisons. The duration of the therapeutic
session in RapidArc is reported to be shorter in comparison to therapeutic time of the other
dynamic techniques. For this reasons, total treatment delivery time in both techniques was
compared and discussed.
Materials and methods: 15 patients with prostate carcinoma were randomly selected for
the analysis. Two competitive treatment plans using respectively the IMRT  and RapidArc
techniques were computed for each patient in Eclipse planning system v. 8.6.15. RPIwin®
application was used for RPI calculations for each treatment plan.
Additionally, total treatment time was compared between IMRT and RapidArc plans. Total
treatment time was a sum of monitor units (MU) for each treated ﬁeld.
Results: The mean values of the RPI indices were insigniﬁcantly higher for IMRT  plans in
comparison to rotational therapy. Comparison of the mean numbers of monitor units con-
ﬁrmed that the use of rotational technique instead of conventional static ﬁeld IMRT can
signiﬁcantly reduce the treatment time.Conclusion: Analysis presented in this paper, demonstrated that RapidArc can compete with
the  IMRT technique in the ﬁeld of treatment plan dosimetry reducing the time required for
dose  delivery.
and C© 2012 Greater Pol
. Backgroundowadays, intensity-modulated radiation therapy (IMRT) is
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dose distribution conformity by modulating the intensity of
the radiation beam in each treated subvolumes. IMRT  has a
potential to minimize doses to surrounding normal or critical
structures and can be safely delivered with a minimum risk
of side effects. However, both fraction time and exposure of
normal tissue to low doses are signiﬁcantly higher for IMRT
than in conventional radiotherapy.1–6
Precise dose adjustment to the tumor geometry is usually
achieved with combinations of several intensity-modulated
ed by Elsevier Urban & Partner Sp. z o.o. All rights reserved.
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doses that cover each of the i-th PTV and j-th OaR structure.348  reports of practical oncology an
ﬁelds distributed among different beam directions.1 Dose dis-
tribution calculation and optimization processes are highly
computerized. Typically, IMRT  dose maps are inversely
planned using dose and volume constraints, as well as pri-
ority factors for each structures which deﬁne acceptable and
penalized dose ranges.
Technological fusion of IMRT  and Arc modalities resulted
in the RapidArc® (Varian Medical Systems) technique which
provides comparable or sometimes even better dosimetric
parameters of dose distribution than IMRT  alone. Beam inten-
sity is modulated continuously during gantry rotation around
the patient’s body. Algorithm for dose calculation in Rapi-
dArc includes angular velocity of the gantry, accelerator mode
(MU/min) and movement  of collimator’s leaves (MLC).
In IMRT  and RapidArc, treatment plans are reported to
provide highly conformal dose distribution with good sparing
of normal tissues.3 However, the duration of the therapeutic
session in RapidArc is reported to be even 8 times shorter
in comparison to therapeutic time of the other dynamic
techniques, which beneﬁts the quality of treatment delivery.
Therefore, RapidArc is presented by some authors as a fast and
simple treatment modality, with precision that matches or
exceeds dose conformity of the IMRT  technique.3,7–10 However,
unambiguous analysis should be done to point whether Rap-
idArc plans are superior to the IMRT  in respect to dosimetric
parameters for a speciﬁc patient plan.
Complex spatial dosimetry of the IMRT and RapidArc
plans hamper the evaluation and comparison between plans
calculated for the two modalities. DVH (Dose Volume His-
togram) analysis reduces spatial dose distribution to the
simple graph and facilitates plan evaluation but not compar-
ison. One dimensional indices calculated based on selected
dosimetric and volumetric parameters of dose distribution
are assumed to provide ranking tools to assist in select-
ing an optimal plan among the alternative ones. Numerous
factors and indices, e.g. conformity index, conformal index,
homogeneity index, etc. were speciﬁed in the literature to
distinguish between plans.11,12 The formulas of the indices
mentioned before, are based mainly on simple rates of
selected dosimetric parameters for target volume and healthy
tissue. More  appropriate analysis of dose distribution, which
takes into account complex shape of the DVH curves and the
priority of each structure, is very often impossible with avail-
able indices.
In 2008, Radiation Planning Index (RPI) was created in the
Radiotherapy and Brachytherapy Planning Department (Cen-
RPI = n+m
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VjOaR · 100% dDter of Oncology – Institute Gliwice branch) for treatment plan
comparisons.13 RPI evaluates simultaneously the dose dis-
tribution in the set of Planning Treatment Volumes (PTVs) andiotherapy 1 7 ( 2 0 1 2 ) 347–351
Organs at Risk (OaR) Moreover, it takes into account dose homo-
geneity in the targets and structure’s priority. It was adapted
to compare the treatment plans computed for more  then one
target volume and for a large number of irradiated structures
with different radiosensitivity and risk of injury. RPI was used
in this paper as an unambiguous tool to compare IMRT  and
RapidArc treatment plans, so as to verify the hypothesis of
the RapidArc superiority in respect to spatial dose distribu-
tion. Moreover, a comparison of time in delivery of IMRT  and
RapidArc dose distribution was also provided in this paper.
2. Aim
The aim of this paper was to compare IMRT  and RapidArc
treatment plans for prostate radiotherapy in respect to RPI
index values and number of monitor units.
3. Materials  and  methods
15 patients with prostate carcinoma were randomly selected
for analysis. Two competitive treatment plans using respec-
tively the IMRT  and RapidArc technique were computed for
each patient in Radiotherapy and Brachytherapy Planning
Department. Dose distributions were calculated with Eclipse
system version 8.6.15. In IMRT, 6 MV and 20 MV photon beams
were planned for treatment depending on the gantry angle,
while in RapidArc only 6 MV photon beams were used for plan-
ning. Total dose of 76 Gy in 2 Gy fractions was delivered in each
technique. Mean number of 9 beams (ranging from 7 to 10) and
not more  than 2 arcs were used respectively in the IMRT  and
RapidArc techniques.
RPIwin® application, designed and developed in 2009 by W.
Osewski, K. S´losarek and J. Guzek in the Center of Oncology
Gliwice Branch (RT and BT Planning Department) was used
for RPI calculations for each treatment plan. RPI values were
assessed basing on each set of DVH curves collected for targets
and OaR structures (Eq. (1)).
·
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(1)
Weight factors (wj parameter in Eq. (1))  in RPIwin application,
which were user-deﬁned input data were established for each
structure. These priority factors which inﬂuence the RPI values
rank the structures from the most important (weight factor is
1) to the least important (weight factor close to 0). In RPI for-
mula n is the number of critical structures and m is the number
of treated volumes. RPI assumes calculation of the integralSDev determines the standard deviation of the dose distribu-
tion in PTV, while pi is a weight factor of the dose distribution
homogeneity for the PTVi. RPI allows comparing treatment
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Table 1 – RPIIMRT and RPIArc values calculated for each treatment plan in the IMRT  and RapidArc techniques. Weight
factors for each group of RPI values represent the criteria of the plan evaluation. Mean values of RPIIMRT and RPIArc
calculated in each group of weight factors are presented on the bottom of the table.
aOARw > PTVw bOARw = PTVw cOARw < PTVw
RPIIMRT RPIARC RPIIMRT RPIARC RPIIMRT RPIARC
1 0.624 0.491 0.619 0.487 0.663 0.547
2 0.644 0.517 0.639 0.515 0.681 0.573
3 0.623 0.584 0.620 0.582 0.662 0.634
4 0.636 0.669 0.634 0.667 0.660 0.714
5 0.647 0.678 0.644 0.676 0.683 0.719
6 0.459 0.485 0.456 0.483 0.524 0.549
7 0.643 0.503 0.639 0.501 0.674 0.557
8 0.744 0.620 0.739 0.616 0.768 0.658
9 0.535 0.382 0.532 0.378 0.589 0.488
10 0.597 0.356 0.593 0.353 0.651 0.460
11 0.615 0.645 0.612 0.622 0.647 0.689
12 0.696 0.598 0.690 0.595 0.717 0.640
13 0.519 0.341 0.515 0.339 0.581 0.440
14 0.623 0.606 0.617 0.603 0.648 0.634
15 0.579 0.526 0.574 0.521 0.617 0.588
Mean RPI 0.612 0.533 0.608 0.529 0.651 0.593
a Risk organs sparing was assumed to be more important than PTV coverage.
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(b Risk organs sparing and PTV coverage equally important.
c Risk organs sparing less important than PTV coverage.
lans calculated for the same patient. Superior plan is rep-
esented by higher values of the RPI. RPI near to 1 corresponds
o a dose distribution that fulﬁls all requirements related to
he PTV coverage of the prescribed dose and dose delivered to
he organs at risk and healthy tissue. On the other hand, RPI
alues near 0 represent dose distribution of low conformity,
omogeneity or undesirable high doses in healthy structures.
RPI calculations were performed three times for each treat-
ent plan in order to obtain three groups of RPI values under
ifferent conditions. Three groups of RPI values were created
epending on the values of weight factors that have been
aken for calculations. Weight factors in these groups of plans
ere set to be:
. higher for OaRs than for PTVs (the ratio OaRw/PTVw > 1),
. equal for OaRs and PTVs (OaRw = PTVw) (the ratio
OaRw/PTVw = 1),
. lower for OaRs than PTVs (the ratio OaRw/PTVw < 1).
Priority index for caput femoris remained 0.5 for each RPI
omputation procedure. In the ﬁrst group, the weight was 1 for
aR, while for PTV, it was set at 0.75. In the third group PTVs
nd OaRs were ranked with weight factors 1 and 0.75, respec-
ively. In all groups, RPIIMRT/RPIArc ratios were calculated to
erify the hypothesis that ratio of the weight factors may inﬂu-
nce the absolute difference between RPIIMRT and RPIArc. The
ollowing assumptions were made to verify if the RPI index
llows pointing out a delivery technique which has an absolute
dvantage over the other treatment delivery techniques:1) Mean value of RPIIMRT/RPIArc > 1 in all three group means
that IMRT  has an absolute advantage over RapidArc treat-
ment delivery technique in respect to both OaR sparing
and PTV dose coverage and homogeneity.(2) Mean RPIIMRT/RPIArc > 1 in the ﬁrst group and
RPIIMRT/RPIArc < 1 in the third group will show that
the IMRT  treatment delivery technique has a potential to
spare healthy tissue better than the rotational technique,
while better target coverage is achieved with the RapidArc
technique.
In addition to the RPI analysis, total treatment time was com-
pared between IMRT and RapidArc plans. Total treatment time
was a sum of monitor units (MU) for each treated ﬁeld. All
graphs and statistics presented in Section 3 were performed
with Microsoft Excel application.
4.  Results
RPI values calculated for each competitive IMRT  and RapidArc
plans for three sets of weight factors are included in Table 1.
The mean values of the RPI indices in each group of weight
factors are presented in Table 1. Statistical signiﬁcance of the
differences between RPIIMRT and RPIArc was evaluated with the
non-parametric method (Sign test was used to verify if there
are differences between medians of the two variables). Dif-
ferences were found to be statistically insigniﬁcant (p = 0.12).
Fig. 1 illustrates differences between values of RPIIMRT and
RPIArc in each of the three groups of weight factors for each
patient.
Total number of Monitor Units (
∑
MU) in IMRT  and Rapi-
dArc plans were evaluated for each patient. Mean number of
monitor units for IMRT was 809 MU (ranging from 576 to 1234)
and for RapidArc it was 442 MU (ranging from 253 to 982). The
difference between
∑
MUIMRT and
∑
MUArc was statistically
signiﬁcant (Sign test; p = 0.01) and illustrated in Fig. 2.
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Fig. 1 – RPIArc/RPIIMRT ratio calculated for each patient and for the three groups of weight factors. Red line represents the
RPIArc/RPIIMRT ratio equal to 1, when no difference between the plans is observed. IMRT  provides better dose distribution
than RapidArc in respect to RPI value for points located below the red line (RPIArc/RPIIMRT < 1). Points located above the red
line represent values of the RPIArc/RPIIMRT ratio which are higher than 1. For these points RapidArc provides better dose
distribution in respect to the RPI index.
5. Discussion
RPI calculations for the IMRT  and RapidArc dose distributions
were performed taking into account three different ratios of
the weight factors for OaR and PTV structures. In each group,
the comparison revealed superiority of the IMRT plans in
Fig. 2 – Mean values of total number of monitor units∑
MU  and standard deviations in the group of plans
calculated for the static ﬁeld IMRT  technique and rotational
technique (
∑
MUIMRT and
∑
MUArc).respect to competitive RapidArc plans; however, the absolute
differences between mean values of RPIIMRT and RPIArc were
marginal.
Statistical signiﬁcance was evaluated in this experiment
and revealed no signiﬁcance between mean RPI values
(p > 0.05) probably because of the small sample group. Further
investigation with larger number of patients is then necessary.
The experiment showed the Radiation Planning Index to
be a useful tool for treatment plan rating when a simple com-
parison of DVH curves for each structure provides ambiguous
results. Dose distribution optimization meets the objectives of
the plan which assumes delivery of the prescribed dose to the
target and simultaneous sparing of normal tissue. Those tasks
are rival and their simultaneous performance is sometimes
impossible. Therefore, it is difﬁcult to decide whether dose dis-
tribution with acceptable OaRs and unsatisfactory target cov-
erage is more  preferable than treatment plan with higher OaRs
doses but appropriate target coverage. Moreover, the deci-
sion making process based only on selected dose constraints
rejects the slope of the DVH curve at the lower dose ranges and
does not take into account the dose homogeneity in the target.
RPI was designed for unambiguous analysis of the whole
dose distribution, represented as a histogram. RPI formula
combines the rival goals of the treatment planning procedure
taking into account dose distribution in all target structures
and all risk volumes. Moreover, RPIWin reads the shape of DVH
radio
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urve supplementing the RPI formula with information about
ose distribution throughout the whole structure.
Additional analysis of the number of monitor units showed
hat RapidArc is a fast treatment delivery method in compar-
son to the IMRT.  Difference between the number of MU was
tatistically signiﬁcant with p < 0.05. In this paper, only pure
ime for dose delivery (expressed in the number of monitor
nits) was taken into account while comparing the two irradi-
tion techniques. Non-coplanar ﬁelds in the IMRT technique
rolonged the treatment session because of the table posi-
ion that had to be changed by the staff between each treated
elds. In our experiment in arc therapy with a single arc, no
able rotation was used. Gantry movements in Rapid Arc are
tilized for dose distribution optimization and dose delivery
ecause the beam is on during gantry rotation. Consequently,
he total time for delivery of the treatment plan is signiﬁcantly
educed in comparison with the “classic” IMRT.
Presented experiment showed that IMRT has an advan-
age over RapidArc treatment delivery technique in respect
o dose distribution. However, the differences are statisti-
ally insigniﬁcant and seem to be illusive. Moreover, relatively
onger treatment time, in respect to the Rapid Arc technique,
ay worsen the precision of the treatment delivery. Longer
atient immobilization and irradiation may increase the risk
f the intrafraction movement.
RapidArc provides dose distributions at almost the same
evel of conformity and homogeneity as the IMRT  technique,
ith treatment times shorter by about 45%. It conﬁrms that
apidArc is a treatment modality that can compete with the
MRT  technique in the ﬁeld of plan dosimetry and treatment
ime delivery.
.  Conclusions
patial dose distributions in the IMRT  and RapidArc tech-
iques shows high level of complexity. Evaluation and
omparison between competitive treatment plans basing
n the spatial distribution of dose values and DVH curves
emains, therefore, an ambiguous task for a physician. Large
umber of structures taken into account during planning,
dditionally hamper selection of the most favorable treatment
lan. Competing goals of treatment planning procedure (tar-
et’s prescription dose and simultaneously critical structure’s
aximal dose) achieved by the rival plans with different
riority levels complicate the comparison between dose
istributions calculated for the patient. Evaluations based
n selected dosimetric or volumetric parameters lead to
he reduction of the spatial dosimetrical information which
ay be crucial for treatment results. Factors and indices
ntroduced by many  authors aid the plan evaluation and
omparisons. RPI index presented in this paper provided an
nambiguous tool for comparison of the dosimetric quality
f IMRT  and RapidArc plans.
Both treatment modalities presented in this paper provided
lmost equivalent dosimetry according to the RPI analysis.
owever, MU  analysis revealed that RapidArc plans can be
elivered in a shorter time by about 45% in comparison to
he IMRT  plans. Risk of the patient movement  during treat-
ent delivery increases with the therapeutic time. This makes
1therapy 1 7 ( 2 0 1 2 ) 347–351 351
the arc therapy a reliable method for treating patients with
prostate cancer.
Conﬂict  of  interest
There is no relationship with the authors (Wojciech
Leszczyn´ski, Krzysztof S´losarek, Marta Szlag) of the
manuscript entitled “Comparison of dose distribution in
IMRT and RapidArc technique in prostate radiotherapy” and
other people or organisations that may cause the conﬂict of
interest with regard to a submitted manuscript.
Financial  disclosure
The study was done under research in Department of Radio-
therapy and Brachytherapy Planning, Maria Skłodowska-Curie
Memorial Cancer Center and Institute of Oncology, Gliwice
Branch, Poland.
 e  f  e  r  e  n  c  e  s
1. www.RadiologyInfo.org.
2. Verbakel WF,  Cuijpers JP, Hoffmans D, et al. Volumetric
intensity-modulated arc therapy vs. conventional IMRT  in
head-and-neck cancer: a comparative planning and
dosimetric study. Int J Radiat Oncol Biol Phys 2009;74:252–9.
3.  Yoo S, Wu JQ, Lee WR, et al. Radiotherapy treatment plans
with RapidArc for prostate cancer involving seminal vesicles
and lymph nodes. Int J Radiat Oncol Biol Phys 2010;76:935–42.
4.  Bindhu J, Supe S, Pawar Y. Intensity modulated radiotherapy
(lMRT) the white, black and grey: a clinical perspective. Rep
Pract Oncol Radiother 2009;14:95–103.
5.  Solaiappan G, Singaravelu G, Prakasarao A, Rabbani B, Supe S.
Inﬂuence of photon beam energy on IMRT plan quality for
radiotherapy of prostate cancer. Rep Pract Oncol Radiother
2009;14:18–31.
6.  Derbyshire SJ, Morgan AM, Thompson RCA, Henry AM,
Thwaites DI. Optimal planning parameters for simultaneous
boost IMRT treatment of prostate cancer using a Beam
ModulatorTM Rep. Pract Oncol Radiother 2010;14:205–13.
7.  Varian Medical Systems. http://www.varian.com.
8.  Zhang P, Happersett L, Yang Y. Optimization of collimator
trajectory in volumetric modulated arc therapy: development
and evaluation for paraspinal SBRT. Int J Radiat Oncol Biol Phys
2010;76:1–9.
9.  Zhang P, Happersett L, Hunt M. Volumetric modulated arc
therapy: planning and evaluation for prostate cancer case. Int
J  Radiat Oncol Biol Phys 2009;73:1–7.
0.  Syam Kumar SA, Vivekanandan Nagarajan, Sriram
Padmanaban. A study on conventional IMRT and RapidArc
treatment planning techniques for head and neck cancers.
Rep Pract Oncol Radiother,
http://dx.doi.org/10.1016/j.rpor.2012.01.009, in press.
1. Feuvret L, Noel G, Mazeron JJ, et al. Conformity index: a
review. Int J Radiat Oncol Biol Phys 2006;64:333–42.
2. Piotrowski T, Martenka P, de Patoul N, et al. The new
two-component conformity index formula (TCCI) and
dose-volume comparisons of the pituitary gland and tonsil
cancer IMRT plans using a linear accelerator and helical
Tomotherapy. Rep Pract Oncol Radiother 2009;14:133–45.
3. S´losarek K, Grza˛dziel A, Szlag M. Radiation Planning Index
for  dose distribution evaluation in stereotactic radiotherapy.
Rep  Pract Oncol Radiother 2008;13:182–6.
